Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on catalytic hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103626630B reveals a novel catalytic hydrogenation route for Rivaroxaban intermediates, offering significant cost reduction and scalable high-purity manufacturing for global supply chains.
Novel patent CN110028461A enables high-purity candesartan cilexetil production with improved supply chain stability and significant cost efficiency for global buyers.
Patent CN114920661A details a cost-effective synthesis of 2-fluoro-3-aminobenzoic acid, a key broflanilide intermediate, offering high purity and scalable manufacturing.
Novel route for 4-trifluoromethyl nicotinic acid offers cost reduction and supply reliability for agrochemical manufacturing partners seeking high-purity intermediates.
Novel nitro-protection route for Lenvatinib achieves 99.7% purity. Reduces toxic reagents and simplifies purification for reliable API intermediate supply.
Patent CN100355733C details a scalable 3-step route for 2-chloro-5-fluoro-nicotinic acid, eliminating toxic thiols and enabling cost-effective pharmaceutical intermediate manufacturing.
Patent CN103172522A details a one-step nickel-catalyzed hydrogenation method for diaminodecalin, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN116730810A reveals high-yield synthesis for steroid intermediates. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN103539596A enables safe formic acid hydrogen transfer for amine synthesis. Offers cost reduction and supply chain reliability for global chemical manufacturers.
Novel synthesis route for 4-aminoindan derivatives via reversed hydrogenation-acylation sequence, offering significant cost reduction in fungicide manufacturing and enhanced supply chain reliability.
Patent CN108707156A reveals optimized clopidogrel bisulfate synthesis. Enhanced yield, simplified purification, and scalable manufacturing for reliable supply chain integration.
Novel patent CN108822112A details high-yield tofacitinib synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN108373442B details a novel recovery method for Avibactam intermediates, transforming waste isomers into high-purity raw materials for efficient API manufacturing.
Patent CN101768174B details a high-yield biapenem preparation using aprotic solvents, offering significant cost reduction and simplified purification for API manufacturers.
Novel patent CN119490551B enables high-purity dydrogesterone production with reduced safety risks and optimized supply chain continuity for global pharmaceutical partners.
Novel preparation method for alkylcyclohexylphenol liquid crystal intermediates via Grignard reaction and one-step hydrogenation, offering high purity and cost reduction for TFT-LCD manufacturing.
Patent CN101643434B details a novel industrial synthesis of Agomelatine using 7-methoxy-1-naphthol, offering significant cost reduction and supply chain reliability for global manufacturers.
Patent CN114907300B details a cost-effective route for Tazemetostat intermediates, offering enhanced purity and scalable manufacturing for global supply chains.
Patent CN113651800A reveals a high-yield route for Oxitinib Mesylate, offering cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN102532149A details a novel asymmetric synthesis for galanthamine and lycoramine. Discover cost-effective, scalable routes for high-purity API manufacturing.